APA (7th ed.) Citation

Khelifi, R. S., Huang, S. J., Savage, K. J., Villa, D., Scott, D. W., Ramadan, K., . . . Gerrie, A. S. (2023). Population-level impact of ibrutinib for chronic lymphocytic leukemia in British Columbia, Canada. Leukemia & Lymphoma, 64(6), 1129. https://doi.org/10.1080/10428194.2023.2199340

Chicago Style (17th ed.) Citation

Khelifi, Rania S., et al. "Population-level Impact of Ibrutinib for Chronic Lymphocytic Leukemia in British Columbia, Canada." Leukemia & Lymphoma 64, no. 6 (2023): 1129. https://doi.org/10.1080/10428194.2023.2199340.

MLA (9th ed.) Citation

Khelifi, Rania S., et al. "Population-level Impact of Ibrutinib for Chronic Lymphocytic Leukemia in British Columbia, Canada." Leukemia & Lymphoma, vol. 64, no. 6, 2023, p. 1129, https://doi.org/10.1080/10428194.2023.2199340.